Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Total Liabilities Summary of Vetoquinol SA

Vetoquinol SA's latest annual total liabilities in 2023 was 165.12 Million EUR , down -1.23% from previous year.
Vetoquinol SA's latest quarterly total liabilities in 2024 Q2 was 163.27 Million EUR , down 0.0% from previous quarter.
Vetoquinol SA reported annual total liabilities of 167.18 Million EUR in 2022, down -8.75% from previous year.
Vetoquinol SA reported annual total liabilities of 183.2 Million EUR in 2021, down -33.2% from previous year.
Vetoquinol SA reported quarterly total liabilities of 165.12 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Vetoquinol SA reported quarterly total liabilities of 165.12 Million EUR for 2023 FY, down -1.23% from previous quarter.

Annual Total Liabilities Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Total Liabilities of Vetoquinol SA (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	165.12 Million EUR	-1.23%
2022	167.18 Million EUR	-8.75%
2021	183.2 Million EUR	-33.2%
2020	274.26 Million EUR	118.56%
2019	125.48 Million EUR	22.43%
2018	102.49 Million EUR	-5.31%
2017	108.24 Million EUR	-11.78%
2016	122.69 Million EUR	-0.23%
2015	122.98 Million EUR	-18.54%
2014	150.96 Million EUR	30.28%
2013	115.87 Million EUR	-9.77%
2012	128.42 Million EUR	20.0%
2011	107.02 Million EUR	-14.5%
2010	125.17 Million EUR	-2.75%
2009	128.72 Million EUR	29.53%
2008	99.37 Million EUR	-1.15%
2007	100.53 Million EUR	1.06%
2006	99.47 Million EUR	-11.89%
2005	112.89 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	163.27 Million EUR	0.0%
2023 Q4	165.12 Million EUR	0.0%
2023 FY	165.12 Million EUR	-1.23%
2023 Q2	143.31 Million EUR	0.0%
2022 Q4	167.18 Million EUR	0.0%
2022 Q2	160.83 Million EUR	0.0%
2022 FY	167.18 Million EUR	-8.75%
2021 Q2	191.51 Million EUR	0.0%
2021 Q4	183.2 Million EUR	0.0%
2021 FY	183.2 Million EUR	-33.2%
2020 Q2	130.52 Million EUR	0.0%
2020 Q4	274.26 Million EUR	0.0%
2020 FY	274.26 Million EUR	118.56%
2019 FY	125.48 Million EUR	22.43%
2019 Q2	117.79 Million EUR	0.0%
2019 Q4	125.48 Million EUR	0.0%
2018 FY	102.49 Million EUR	-5.31%
2018 Q4	102.49 Million EUR	0.0%
2018 Q2	99.08 Million EUR	0.0%
2017 FY	108.24 Million EUR	-11.78%
2017 Q4	108.24 Million EUR	0.0%
2017 Q2	111.91 Million EUR	0.0%
2016 Q2	115.23 Million EUR	0.0%
2016 FY	122.69 Million EUR	-0.23%
2016 Q4	122.69 Million EUR	0.0%
2015 FY	122.98 Million EUR	-18.54%
2015 Q2	140.64 Million EUR	0.0%
2015 Q4	122.98 Million EUR	0.0%
2014 Q2	142.88 Million EUR	0.0%
2014 FY	150.96 Million EUR	30.28%
2014 Q4	150.96 Million EUR	0.0%
2013 Q4	115.87 Million EUR	0.0%
2013 FY	115.87 Million EUR	-9.77%
2013 Q2	124.01 Million EUR	0.0%
2012 Q4	128.42 Million EUR	0.0%
2012 Q2	115.62 Million EUR	0.0%
2012 FY	128.42 Million EUR	20.0%
2011 Q4	107.02 Million EUR	0.0%
2011 FY	107.02 Million EUR	-14.5%
2010 Q2	112.66 Million EUR	0.0%
2010 Q4	125.17 Million EUR	0.0%
2010 FY	125.17 Million EUR	-2.75%
2009 Q4	128.72 Million EUR	0.0%
2009 FY	128.72 Million EUR	29.53%
2008 FY	99.37 Million EUR	-1.15%
2007 FY	100.53 Million EUR	1.06%
2006 FY	99.47 Million EUR	-11.89%
2005 FY	112.89 Million EUR	0.0%

Peer Total Liabilities Comparison of Vetoquinol SA

Name	Total Liabilities	Total Liabilities Difference
Boiron SA	198.7 Million EUR	16.899%
Laboratorios Farmaceuticos Rovi, S.A.	256.39 Million EUR	35.597%
Valneva SE	341.14 Million EUR	51.598%
AB Science S.A.	46.5 Million EUR	-255.04%
Nanobiotix S.A.	95.74 Million EUR	-72.469%
PHAXIAM Therapeutics S.A.	25.69 Million EUR	-542.623%
Vivoryon Therapeutics N.V.	4.54 Million EUR	-3531.449%
BioSenic S.A.	32.26 Million EUR	-411.784%
ABIVAX Société Anonyme	131.05 Million EUR	-25.997%
Formycon AG	387.61 Million EUR	57.4%